A Study of CTA101 UCAR-T Cell Injection in Patients With Relapsed or Refractory CD19+ B-line Hematological Malignancy

Clinical trial NCT04227015 · RECRUITING

Trial details

NCT number: NCT04227015
Sponsor: He Huang
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Acute Lymphoblastic Leukemia Non-hodgkin Lymphoma

Start date: 2020-01-08
Primary completion: 2022-01-08
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.